About Cryo-Cell
Cryo-Cell is a company based in Oldsmar (United States) founded in 1989. The company has 82 employees as of November 30, 2024. Cryo-Cell has completed 1 acquisition, including CORD:USE Cord Blood. Cryo-Cell operates in a competitive market with competitors including China Cord Blood Corporation, BioLife Plasma Services, Cellcolabs, FamilyCord and Lazo de Vida, among others.
- Headquarter Oldsmar, United States
- Employees 82 as on 30 Nov, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cryo-Cell International, Inc.
-
Annual Revenue
$31.99 M (USD)2.05as on Nov 30, 2024
-
Net Profit
$402.1 K (USD)0as on Nov 30, 2024
-
EBITDA
$4.81 M (USD)228.85as on Nov 30, 2024
-
Latest Funding Round
$1.8 M (USD), Post-IPO
Dec 02, 1999
-
Investors
Not available
-
Employee Count
82
as on Nov 30, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cryo-Cell
Cryo-Cell is a publicly listed company on the AMEX with ticker symbol CCEL in USA, operating in the Transportation sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Cryo-Cell
Unlock access to complete
Unlock access to complete
Medical Team
2 people
Software Development Team
1 people
Leadership Team
1 people
CIO Team
1 people
Unlock access to complete
Funding Insights of Cryo-Cell
Investments & Acquisitions by Cryo-Cell
Cryo-Cell has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CORD:USE Cord Blood.
Investment portfolio details for Cryo-Cell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of umbilical cord blood stem cell storage services
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Cryo-Cell
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cryo-Cell
Detailed financials for Cryo-Cell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cryo-Cell Comparisons
Peer comparison for Cryo-Cell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cryo-Cell
Cryo-Cell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as China Cord Blood Corporation, BioLife Plasma Services, Cellcolabs, FamilyCord and Lazo de Vida, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Umbilical cord blood stem cell banking services are provided.
|
|
| Locked | Locked | Locked |
BioLife Plasma Services collects high-quality plasma and processes it into lifesaving therapies.
|
|
| Locked | Locked | Locked |
Stem cell banking services are provided for the healthcare sector.
|
|
| Locked | Locked | Locked |
Provides comprehensive stem cell storage services for individuals.
|
|
| Locked | Locked | Locked |
Provider of stem cell banking services
|
Detailed competitors of Cryo-Cell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cryo-Cell
Complete news archive for Cryo-Cell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cryo-Cell
Cryo-Cell was founded in 1989 and raised its 1st funding round 10 years after it was founded.
Cryo-Cell is headquartered in Oldsmar, United States. It is registered at Oldsmar, Florida, United States.
As of Nov 30, 2024, the latest employee count at Cryo-Cell is 82.
Annual revenue of Cryo-Cell is $31.99M as on Nov 30, 2024.
Cryo-Cell is a cord blood bank to separate and store stem cells. The company services include umbilical cord blood, cord tissue, and menstrual stem cell banking. The premium service includes cryopreservation of cord tissue mesenchymal stem cells that can differentiate into bone, muscle, fat, and cartilage tissue.
Cryo-Cell's top competitors include China Cord Blood Corporation, Cellcolabs and Lazo de Vida.
Yes, Cryo-Cell is publicly traded on AMEX under the ticker symbol CCEL.
Cryo-Cell has made 1 acquisition, including CORD:USE Cord Blood.
The ticker symbol of Cryo-Cell is CCEL on AMEX.